Travoprost ophthalmic solution

Alembic Pharmaceuticals Limited🇺🇸 United States

FDA Page

Effective Date: Dec 22, 2025
Approval ID: da11bb76-fa62-4800-8a4e-cc76f4351e0d
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TRAVOPROST OPHTHALMIC SOLUTION (Ionic Buffered Solution) safely and effectively. See full prescribing information for TRAVOPROST OPHTHALMIC SOLUTION (Ionic Buffered Solution). TRAVOPROST ophthalmic solution (Ionic Buffered Solution), for topical ophthalmic use Initial U.S. Approval: 2001

Quick Stats

Total Products1

Labelers1

Label Sections28

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.